Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan | BMC Gastroenterology

  • Kato M, Ota H, Okuda M, Kikuchi S, Satoh K, Shimoyama T, Suzuki H, Handa O, Furuta T, Mabe K et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 revised edition. Helicobacter 2019, 24(4):e12597.

  • Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer (IARC Working Group Report Volume 8). Lyon, France: International Agency for Research on Cancer; 2014.

  • Health, Labour and Welfare Statistics Association. 国民衛生動向 2024/2025. J Health Welfare Stat. 2024;71(9):1–412.

  • Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52(24):6735–40.

    CAS 
    PubMed 

    Google Scholar 

  • Schlemper RJ, van der Werf SD, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol. 1996;8(1):33–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Schultze V, Hackelsberger A, Gunther T, Miehlke S, Roessner A, Malfertheiner P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol. 1998;33(2):137–42.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, Gurer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001;96(3):666–72.

    Article 

    Google Scholar 

  • Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther. 2005;21(9):1121–6.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Tahara T, Shibata T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N. A possible link between gastric mucosal atrophy and gastric cancer after Helicobacter pylori eradication. PLoS One. 2016;11(10): e0163700.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Adachi K, Kishi K, Sakamoto U, Ishimura N, Ishihara S. Degree of gastric mucosal atrophy correlated well with gastric cancer occurrence in patients with Helicobacter pylori-eradicated status. Intern Med. 2023;62(10):1389–94.

    Article 
    PubMed 

    Google Scholar 

  • Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100(5):1037–42.

    Article 
    PubMed 

    Google Scholar 

  • Kishikawa H, Ojiro K, Nakamura K, Katayama T, Arahata K, Takarabe S, Miura S, Kanai T, Nishida J. Previous Helicobacter pylori infection–induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication. Helicobacter. 2020;25(1): e12669.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • 人を対象とする生命科学・医学系研究に関する倫理指針ガイダンス (日本語) (Revised: 令和6年4月1日) [https://www.mhlw.go.jp/content/001237478.pdf]

  • Projected cancer incidence in 2023 [https://ganjoho.jp/reg_stat/statistics/stat/short_pred_en.html]

  • Sugano K, Moss SF, Kuipers EJ. Gastric intestinal metaplasia: real culprit or innocent bystander as a precancerous condition for gastric cancer? Gastroenterology. 2023;165(6):1352–66.e1351.

    Article 
    PubMed 

    Google Scholar 

  • Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019;68(1):11–7.

    Article 
    PubMed 

    Google Scholar 

  • Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T, Fukayama M, Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–24.

    Article 
    PubMed 

    Google Scholar 

  • Take S, Mizuno M, Ishiki K, Kusumoto C, Imada T, Hamada F, Yoshida T, Yokota K, Mitsuhashi T, Okada H. Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. J Gastroenterol. 2020;55(3):281–8.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Karita M, Noriyasu A, Kosako E, Teramukai S, Matsumoto S. Relationship between pepsinogen I&II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases. Dig Dis Sci. 2003;48(9):1839–45.

  • Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol. 2015;21(16):4954–60.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Shichijo S, Uedo N, Michida T. Detection of early gastric cancer after Helicobacter pylori eradication. Digestion. 2022;103(1):54–61.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, Oguma K, Okada H, Yamamoto K. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46(3):318–24.

    Article 
    PubMed 

    Google Scholar 

  • Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22(3):435–45.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–24.e1115.

    Article 
    PubMed 

    Google Scholar 

  • Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–21.

    Article 
    PubMed 

    Google Scholar 

  • Ford AC, Yuan Y, Moayyedi P. Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: a meta-analysis beyond 10 years of follow-up. Gastroenterology. 2022;163(3):754–6.e751.

    Article 
    PubMed 

    Google Scholar 

  • Pimenta-Melo AR, Monteiro-Soares M, Libanio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041–9.

    Article 
    PubMed 

    Google Scholar 

  • Ono S, Kawada K, Dohi O, Kitamura S, Koike T, Hori S, Kanzaki H, Murao T, Yagi N, Sasaki F, et al. Linked color imaging focused on neoplasm detection in the upper gastrointestinal tract : a randomized trial. Ann Intern Med. 2021;174(1):18–24.

    Article 
    PubMed 

    Google Scholar 

  • Kobayashi M, Nishioji K, Kamaguchi M. Recommendations for stomach cancer screening during Helicobacter pylori eradication era [in Japanese]. Journal of Gastrointestinal Cancer Screening. 2019;57(6):1114–27.

    Google Scholar 

  • Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF Jr, Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kato M, Ono S, Mori Y, Nakagawa M, Mabe K, Kudo T. Characteristics of gastric cancer after eradication of Helicobacter pylori – from a clinical point of view [in Japanese]. Stomach Intestine. 2012;47(11):1640–8.

    Google Scholar 

  • Okada K, Suzuki S, Naito S, Yamada Y, Haruki S, Kubota M, Nakajima Y, Shimizu T, Ando K, Uchida Y et al. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication. Gastrointest Endosc. 2019;89(6):1152–9.e1151.

  • Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–95.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nishizawa T, Suzuki H, Arano T, Yoshida S, Yamashita H, Hata K, Kanai T, Yahagi N, Toyoshima O. Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori. J Clin Biochem Nutr. 2016;59(3):226–30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Fiddian-Green RG, Bank S, Marks IN, Louw JH. Maximum acid output and position of peptic ulcers. Lancet. 1976;2(8000):1370–3.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Oi M, Oshida K, Sugimura S. The location of gastric ulcer. Gastroenterology. 1959;36(1):45–56.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Rumball JM. Chapter 7 – Coexistent duodenal ulcer. Gastroenterology. 1971;61(4):622–7.

  • Oi M. Peptic ulcer and gastric acidity: a new look at an old aphorism, “the higher the ulcer, the lower the acidity.” J Gastroenterol. 1995;30(1):122–7.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Tatsuta M, Iishi H, Okuda S. Location of peptic ulcers in relation to antral and fundal gastritis by chromoendoscopic follow-up examinations. Dig Dis Sci. 1986;31(1):7–11.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wu MS, Wang HP, Wang JT, Wang TH, Lin JT. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater. J Gastroenterol Hepatol. 1995;10(4):401–4.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Mori H, Suzuki H, Omata F, Masaoka T, Asaoka D, Kawakami K, Mizuno S, Kurihara N, Nagahara A, Sakaki N, et al. Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients. Therap Adv Gastroenterol. 2019;12:1756284819858511.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Howden CW, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, Sugano K. Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. Therap Adv Gastroenterol. 2023;16:17562848231168714.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hiroi S, Sugano K, Tanaka S, Kawakami K. Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ Open. 2017;7(7): e015855.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Tokunaga K, Suzuki C, Hasegawa M, Fujimori I. Cost analysis in Helicobacter pylori eradication therapy based on a database of health insurance claims in Japan. Clinicoecon Outcomes Res. 2021;13:241–50.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Continue Reading